Baird Financial Group, Inc. Simulations Plus, Inc. Transaction History

Baird Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$38.46 - $50.95 $34,421 - $45,600	-895 Reduced 17.55%	4,205 $204,000
Q1 2024 May 14, 2024	BUY	$37.48 - $44.74 $22,712 - $27,112	606 Added 13.48%	5,100 $209,000
Q4 2023 Feb 14, 2024	SELL	$33.36 - $45.71 $355,083 - $486,537	-10,644 Reduced 70.31%	4,494 $201,000
Q3 2023 Nov 13, 2023	BUY	$40.03 - $51.51 $605,974 - $779,758	15,138 New	15,138 $631,000
Q3 2022 Nov 14, 2022	SELL	$47.75 - $66.88 $29,127 - $40,796	-610 Reduced 11.91%	4,510 $219,000
Q2 2022 Aug 08, 2022	SELL	$40.55 - $51.76 $4,460 - $5,693	-110 Reduced 2.1%	5,120 $253,000
Q1 2022 May 13, 2022	SELL	$36.56 - $50.98 $2,339 - $3,262	-64 Reduced 1.21%	5,230 $267,000
Q4 2021 Feb 09, 2022	BUY	$37.1 - $57.45 $196,407 - $304,140	5,294 New	5,294 $250,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $591M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.